CLINICAL_TRIALS
trial_result
· 2016-08-16
Clinical Trial Update: BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. [Phase 4]
Summary
Phase 4 trial update of a protease inhibitor used with Enfuvirtide (Fuzeon) in treatment-experienced HIV-1 patients; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2016-08-16